Compare Microchip Technology Inc. (MCHP) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs Oscar Health Inc — how do they compare? Microchip Technology Inc. trades at $75.55 (market cap $41.01B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Microchip Technology Inc. is far larger — about 4× Oscar Health Inc's market cap, and Microchip Technology Inc. pays a 2.41% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Microchip Technology Inc. for 63 Days and Oscar Health Inc for 15 Days on average.
| MCHP | OSCR | |
|---|---|---|
Market Cap | $41.01B | $10.22B |
Volume | 9,972,516 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $102.97 | $33.81 |
52-Week Low | $49.02 | $10.85 |
Typical Hold Time | 63 Days | 15 Days |
Enterprise Value | $46.13B | $6.57B |
Dividend Yield | 2.41% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MCHP trades at $75.52, down 3.2% over 24 hours, with a bearish technical signal from moving averages. The company reported a net loss of -$500K in 2025, though it has beaten EPS estimates in recent quarters. Analyst consensus is strongly bullish with a $110.50 price target, supported by positive news on product expansions in Ethernet and 48V power portfolios and the completion of the Hailo acquisition.
The outlook is mixed: strong analyst support and strategic expansions in high-growth areas like AI and automotive present upside, but high valuation ratios, significant debt, and recent profitability challenges pose risks. Investor sentiment is cautiously optimistic amid sector tailwinds.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
